El Salvador vs Kuwait: The number of people with susceptibility test result for rifampicin
El Salvador
316
in 2021
Kuwait
401
in 2021
El Salvador rank
87th
Kuwait rank
85th
The number of people with susceptibility test result for rifampicin over time
- El Salvador
- Kuwait
How they compare
Kuwait currently reports 401 against 316 in El Salvador, a difference of 85.
That makes Kuwait's figure about 1.3 times El Salvador's.
The two have swapped places 1 time across 5 shared years of data; in 2017 it was El Salvador ahead.
El Salvador ranks 87th and Kuwait ranks 85th of 155 countries.
El Salvador has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | El Salvador | Kuwait | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 844.33 | 346.33 | 498 | El Salvador |
| 2020s | 418.5 | 350 | 68.5 | El Salvador |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, El Salvador or Kuwait?
- Kuwait, at 401 against 316 in El Salvador as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between El Salvador and Kuwait?
- 85, with Kuwait ahead.
- How many years of comparable data are there for El Salvador and Kuwait?
- 5 years are reported by both, from 2017 to 2021.
- How do El Salvador and Kuwait rank globally for the number of people with susceptibility test result for rifampicin?
- El Salvador ranks 87th and Kuwait ranks 85th of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.